ANNEXON, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
ANNEXON, INC. (ANNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum of 91.90% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum · last filed 2026-08-12
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2026-06-30 was 91.90%, a 2.03% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2026-03-31 was 92.30%, a 1.60% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2025-06-30 was 93.80%, a 4.09% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for the quarter ending 2025-03-31 was 93.80%, a 2.49% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2025 was 93.80%, a 6.01% decline from fiscal 2024.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2024 was 99.80%, a 21.12% increase from fiscal 2023.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2023 was 82.40%, a 4.07% decline from fiscal 2022.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, maximum for fiscal 2022 was 85.90%, a 5.29% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 91.90% 10-Q · filed 2026-08-12 | 92.30% 10-Q · filed 2026-08-12 | ||||
| 2026-03-31 | 92.30% 10-Q · filed 2026-05-07 | |||||
| 2025-12-31 | 93.80% 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | 93.80% 10-Q · filed 2025-11-10 | |||||
| 2025-06-30 | 93.80% 10-Q · filed 2026-08-12 | 93.80% 10-Q · filed 2026-08-12 | ||||
| 2025-03-31 | 93.80% 10-Q · filed 2026-05-07 | |||||
| 2024-12-31 | 99.80% 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | 97.60% 10-Q · filed 2025-11-10 | 97.80% 10-Q · filed 2025-11-10 | ||||
| 2024-06-30 | 97.80% 10-Q · filed 2025-08-14 | 97.80% 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | 96.20% 10-Q · filed 2025-05-12 | |||||
| 2023-12-31 | 82.40% 10-K · filed 2025-03-03 | |||||
| 2023-09-30 | 81.90% 10-Q · filed 2024-11-14 | 82.40% 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | 82.40% 10-Q · filed 2024-08-12 | 82.40% 10-Q · filed 2024-08-12 | ||||
| 2023-03-31 | 81.50% 10-Q · filed 2024-05-13 | 82.00% 10-Q · filed 2023-05-08 | ||||
| 2022-12-31 | 85.90% 10-K · filed 2024-03-26 | |||||
| 2022-09-30 | 82.70% 10-Q · filed 2023-11-13 | 82.80% 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 82.80% 10-Q · filed 2023-08-07 | 82.80% 10-Q · filed 2023-08-07 | ||||
| 2022-03-31 | 82.00% 10-Q · filed 2023-05-08 | |||||
| 2021-12-31 | 90.70% 10-K · filed 2023-03-06 | 91.00% 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | 89.00% 10-Q · filed 2022-11-03 | 90.70% 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | 90.70% 10-Q · filed 2022-08-08 | 90.70% 10-Q · filed 2022-08-08 | ||||
| 2020-12-31 | 93.00% 10-K · filed 2022-03-01 | |||||
| 2020-09-30 | 93.00% 10-Q · filed 2021-11-09 | 93.00% 10-Q · filed 2021-11-09 | ||||
| 2019-12-31 | 77.00% 10-K · filed 2021-03-25 | |||||
| 2019-09-30 | 77.00% 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |